Inhaler training study aims to cut COPD errors
NCT ID NCT02813200
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well people with COPD can learn to use three different inhaler devices: Diskus, Breezhaler, and Respimat. Twenty-four participants were taught to use each device and then checked for mistakes. The goal is to find better ways to train patients so they get the full benefit of their medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Seretide Diskus, Ultibro Breezhaler, Spiriva Respimat
What this could lead to
If successful, this could help doctors teach patients how to use inhalers correctly, leading to better symptom control and fewer hospital visits.
What could go wrong
This is a small, completed study (24 people) that only looks at learning ability, not long-term health outcomes. Results may not apply to all COPD patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque
Bordeaux, 33604, France